Dailypharm Live Search Close

[Reporter's View] what 'AI-driven drug discovery' requires

By Kim, Jin-Gu | translator Hong, Ji Yeon

24.11.26 05:17:31

°¡³ª´Ù¶ó 0



This year¡¯s Nobel Prize in Chemistry was jointly awarded to David Baker, a professor at the University of Washington, Demis Hassabis, CEO of Google DeepMind, and John Jumper, Director at DeepMind. Professor Baker was recognized for his contribution to creating protein design models. The DeepMind team was honored for developing 'AlphaFold,' which reduced the time required for protein structure prediction from years to mere hours using AI.

The potential of AI in drug development has once again been recognized following the winning of the Nobel Prize. At the same time, it has alleviated concerns that AI-driven drug discovery is just chasing a mirage.

In South Korea, various AI-driven drug

Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)